Literature DB >> 27035941

Dopamine synapse is a neuroligin-2-mediated contact between dopaminergic presynaptic and GABAergic postsynaptic structures.

Motokazu Uchigashima1, Toshihisa Ohtsuka2, Kazuto Kobayashi3, Masahiko Watanabe4.   

Abstract

Midbrain dopamine neurons project densely to the striatum and form so-called dopamine synapses on medium spiny neurons (MSNs), principal neurons in the striatum. Because dopamine receptors are widely expressed away from dopamine synapses, it remains unclear how dopamine synapses are involved in dopaminergic transmission. Here we demonstrate that dopamine synapses are contacts formed between dopaminergic presynaptic and GABAergic postsynaptic structures. The presynaptic structure expressed tyrosine hydroxylase, vesicular monoamine transporter-2, and plasmalemmal dopamine transporter, which are essential for dopamine synthesis, vesicular filling, and recycling, but was below the detection threshold for molecules involving GABA synthesis and vesicular filling or for GABA itself. In contrast, the postsynaptic structure of dopamine synapses expressed GABAergic molecules, including postsynaptic adhesion molecule neuroligin-2, postsynaptic scaffolding molecule gephyrin, and GABAA receptor α1, without any specific clustering of dopamine receptors. Of these, neuroligin-2 promoted presynaptic differentiation in axons of midbrain dopamine neurons and striatal GABAergic neurons in culture. After neuroligin-2 knockdown in the striatum, a significant decrease of dopamine synapses coupled with a reciprocal increase of GABAergic synapses was observed on MSN dendrites. This finding suggests that neuroligin-2 controls striatal synapse formation by giving competitive advantage to heterologous dopamine synapses over conventional GABAergic synapses. Considering that MSN dendrites are preferential targets of dopamine synapses and express high levels of dopamine receptors, dopamine synapse formation may serve to increase the specificity and potency of dopaminergic modulation of striatal outputs by anchoring dopamine release sites to dopamine-sensing targets.

Entities:  

Keywords:  dopamine synapse; medium spiny neuron; neuroligin-2; striatum

Mesh:

Substances:

Year:  2016        PMID: 27035941      PMCID: PMC4839454          DOI: 10.1073/pnas.1514074113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

Review 1.  Understanding wiring and volume transmission.

Authors:  Luigi F Agnati; Diego Guidolin; Michele Guescini; Susanna Genedani; Kjell Fuxe
Journal:  Brain Res Rev       Date:  2010-03-27

2.  Key modulatory role of presynaptic adenosine A2A receptors in cortical neurotransmission to the striatal direct pathway.

Authors:  César Quiroz; Rafael Luján; Motokazu Uchigashima; Ana Patrícia Simoes; Talia N Lerner; Janusz Borycz; Anil Kachroo; Paula M Canas; Marco Orru; Michael A Schwarzschild; Diane L Rosin; Anatol C Kreitzer; Rodrigo A Cunha; Masahiko Watanabe; Sergi Ferré
Journal:  ScientificWorldJournal       Date:  2009-11-18

3.  Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines.

Authors:  T F Freund; J F Powell; A D Smith
Journal:  Neuroscience       Date:  1984-12       Impact factor: 3.590

Review 4.  From glutamate co-release to vesicular synergy: vesicular glutamate transporters.

Authors:  Salah El Mestikawy; Asa Wallén-Mackenzie; Guillaume M Fortin; Laurent Descarries; Louis-Eric Trudeau
Journal:  Nat Rev Neurosci       Date:  2011-04       Impact factor: 34.870

5.  Expression and distribution of JNK/SAPK-associated scaffold protein JSAP1 in developing and adult mouse brain.

Authors:  Eriko Miura; Masahiro Fukaya; Tokiharu Sato; Kazushi Sugihara; Masahide Asano; Katsuji Yoshioka; Masahiko Watanabe
Journal:  J Neurochem       Date:  2006-04-05       Impact factor: 5.372

6.  Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin.

Authors:  Alexandros Poulopoulos; Gayane Aramuni; Guido Meyer; Tolga Soykan; Mrinalini Hoon; Theofilos Papadopoulos; Mingyue Zhang; Ingo Paarmann; Céline Fuchs; Kirsten Harvey; Peter Jedlicka; Stephan W Schwarzacher; Heinrich Betz; Robert J Harvey; Nils Brose; Weiqi Zhang; Frédérique Varoqueaux
Journal:  Neuron       Date:  2009-09-10       Impact factor: 17.173

7.  Phasic dopamine release drives rapid activation of striatal D2-receptors.

Authors:  Pamela F Marcott; Aphroditi A Mamaligas; Christopher P Ford
Journal:  Neuron       Date:  2014-09-18       Impact factor: 17.173

8.  Conditional ablation of striatal neuronal types containing dopamine D2 receptor disturbs coordination of basal ganglia function.

Authors:  Hiromi Sano; Yasunobu Yasoshima; Natsuki Matsushita; Takeshi Kaneko; Kenji Kohno; Ira Pastan; Kazuto Kobayashi
Journal:  J Neurosci       Date:  2003-10-08       Impact factor: 6.167

9.  GABAergic basket cells expressing cholecystokinin contain vesicular glutamate transporter type 3 (VGLUT3) in their synaptic terminals in hippocampus and isocortex of the rat.

Authors:  Jozsef Somogyi; Agnès Baude; Yuko Omori; Hidemi Shimizu; Salah El Mestikawy; Masahiro Fukaya; Ryuichi Shigemoto; Masahiko Watanabe; Peter Somogyi
Journal:  Eur J Neurosci       Date:  2004-02       Impact factor: 3.386

10.  A dopaminergic axon lattice in the striatum and its relationship with cortical and thalamic terminals.

Authors:  Jonathan Moss; J Paul Bolam
Journal:  J Neurosci       Date:  2008-10-29       Impact factor: 6.167

View more
  35 in total

Review 1.  A negative regulator of synaptic development: MDGA and its links to neurodevelopmental disorders.

Authors:  Rui Wang; Jia-Xian Dong; Lu Wang; Xin-Yan Dong; Eitan Anenberg; Pei-Fang Jiang; Ling-Hui Zeng; Yi-Cheng Xie
Journal:  World J Pediatr       Date:  2019-04-17       Impact factor: 2.764

2.  Differential expression of neurexin genes in the mouse brain.

Authors:  Motokazu Uchigashima; Amy Cheung; Julie Suh; Masahiko Watanabe; Kensuke Futai
Journal:  J Comp Neurol       Date:  2019-02-25       Impact factor: 3.215

3.  A Critical Role for Dopamine D5 Receptors in Pain Chronicity in Male Mice.

Authors:  Salim Megat; Stephanie Shiers; Jamie K Moy; Paulino Barragan-Iglesias; Grishma Pradhan; Rebecca P Seal; Gregory Dussor; Theodore J Price
Journal:  J Neurosci       Date:  2017-11-22       Impact factor: 6.167

Review 4.  Alteration of GABAergic neurotransmission in Huntington's disease.

Authors:  Maurice Garret; Zhuowei Du; Marine Chazalon; Yoon H Cho; Jérôme Baufreton
Journal:  CNS Neurosci Ther       Date:  2018-02-21       Impact factor: 5.243

5.  Neuroligin3 splice isoforms shape inhibitory synaptic function in the mouse hippocampus.

Authors:  Motokazu Uchigashima; Ming Leung; Takuya Watanabe; Amy Cheung; Timmy Le; Sabine Pallat; Alexandre Luis Marques Dinis; Masahiko Watanabe; Yuka Imamura Kawasawa; Kensuke Futai
Journal:  J Biol Chem       Date:  2020-05-07       Impact factor: 5.157

6.  Dopamine Secretion Is Mediated by Sparse Active Zone-like Release Sites.

Authors:  Changliang Liu; Lauren Kershberg; Jiexin Wang; Shirin Schneeberger; Pascal S Kaeser
Journal:  Cell       Date:  2018-02-01       Impact factor: 41.582

Review 7.  Dopaminergic dysfunction in neurodevelopmental disorders: recent advances and synergistic technologies to aid basic research.

Authors:  J Elliott Robinson; Viviana Gradinaru
Journal:  Curr Opin Neurobiol       Date:  2017-08-30       Impact factor: 6.627

Review 8.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 9.  Synaptic Neurexin Complexes: A Molecular Code for the Logic of Neural Circuits.

Authors:  Thomas C Südhof
Journal:  Cell       Date:  2017-11-02       Impact factor: 41.582

10.  In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET.

Authors:  Majken B Thomsen; Jan Jacobsen; Thea P Lillethorup; Anna C Schacht; Mette Simonsen; Marina Romero-Ramos; David J Brooks; Anne M Landau
Journal:  J Cereb Blood Flow Metab       Date:  2020-06-14       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.